SEC filing · 20-F

Datasea Intelligent Technology Ltd.: Annual report (foreign issuer)

Datasea transitioned toward acoustic healthcare and AI agents as third-party revenue fell but gross profit improved in fiscal 2026.

Filed October 2, 2026 · period ended June 30, 2026

Mixed for the company

What the numbers say

Revenue fell 43% to $40.7M versus the prior year; operating margin widened from -7.2% to -5.7%; diluted EPS -$0.23 versus -$0.77; operating cash flow $2M (a year earlier -$2.4M); free cash flow $2M (a year earlier -$2.4M); cash fell by $278.2K to $316.5K; diluted share count up 46% (dilution).

Compared with the same period a year earlier, from the figures Datasea Intelligent Technology Ltd. reported to the SEC.

What happened

The company shifted focus to acoustic medical products such as NeuroVibe and AI execution agents while cutting lower-margin digital services.

The full interpretation is in the app

Why it matters, the key numbers from the document and what to watch next: the full interpretation of every report is part of Pro.

Read the full interpretation

Read the original

Filing document on SEC.gov All documents of this filing

Back to Datasea Intelligent Technology Ltd.

Summary generated automatically from the filing text and checked against it: every number above is printed in the document. It describes the filing and is not investment advice. Read the original before relying on it.